ArticleScience in One Health2026
Bridging policy and practice: implementation of emerging infectious disease risk assessment in China from a One Health perspective.
Article in Science in One Health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Risk assessment of emerging infectious diseases (EIDs) enables the early identification of potential threats and informs timely public health responses. A One Health perspective may enhance its comprehensiveness by integrating human, animal, and environmental factors. However, current understanding of the policy implementation of EID risk assessment in China remains limited. This study examines the implementation of related policies in China to identify gaps between policy design and practice from a One Health perspective. Methods: Semi-structured interviews were performed in Hainan Province and Jiangxi Province during March and June in 2024. Purposive sampling was used to recruit stakeholders from human, animal, environment, and other administrative sectors. All interviews were conducted in Chinese with each lasting 40-60 min. Grounded theory methodology was used to guide thematic analysis. Open coding and axial coding were conducted to allow themes and subthemes from the data. Results: A total of 54 experts from human (25.9%), animal (24.1%), environment (22.2%) and other (27.8%) sectors participated in the interview. Overall, China advanced risk assessment of EIDs across multiple dimensions, including governance system, cross-sectoral coordination, technology, workforce capacity, and financial investment. The results revealed barriers in implementing of risk assessment, including: (1) minimal surveillance of unknown diseases, (2) minimal surveillance of aquatic and wild animals, (3) insufficient staffing size and weak professional competence, and (4) inadequate cross-sectoral collaboration. It is recommended to improve legal provisions concerning sector responsibilities, develop a minimum data set to facilitate cross-sectoral collaboration, enhance work force capacity through training, and strengthen scientific research cooperation between academic communities and sectors. Conclusion: Persistent gaps in the local implementation of policies on EID risk assessment in China were identified. The findings highlighted the need to strengthen risk surveillance and facilitate data sharing across multiple sectors from One Health perspective, which may contribute to China's capacities to cope with EIDs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.